Profile
Mia Kelley worked as an Attorney at Wilmer Cutler Pickering Hale & Dorr LLP.
She then served as Vice President at PureTech Health Plc from 2016 to 2020.
Currently, she is the Secretary, VP-Legal Affairs & General Counsel at Karuna Therapeutics, Inc. starting in 2020.
Ms. Kelley completed her undergraduate degree at Emory University and her graduate degree at Northwestern University.
Former positions of Mia Kelley
| Companies | Position | End |
|---|---|---|
| KARA THER | General Counsel | 18/03/2024 |
| PURETECH HEALTH PLC | Corporate Officer/Principal | 01/04/2020 |
Wilmer Cutler Pickering Hale & Dorr LLP
 Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Training of Mia Kelley
| Emory University | Undergraduate Degree |
| Northwestern University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PURETECH HEALTH PLC | Health Technology |
| Private companies | 2 |
|---|---|
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Commercial Services |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Mia Kelley